Voting Rights Announcements | 1 June 2010 20:26
STRATEC Biomedical Systems AG / Release of an announcement according to Article 21, Section 1 of the WpHG [the German Securities Trading Act] (share)
01.06.2010 20:26
Dissemination of a Voting Rights announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
1st voting rights anouncement
FIL Limited, Hamilton, Bermuda, has notified us pursuant to section 21 (1)
WpHG on 21 May 2010, that on 17 May 2010 the share of voting rights in
STRATEC Biomedical Systems AG, Birkenfeld, Germany, ISIN: DE0007289001 fell
below the threshold of 3% and that the percentage of voting rights on that
day amounted to 2.04% (233,373 voting rights).
Of this amount, 0.07% (8,380 voting rights) is to be attributed pursuant
section 22 (1) sent. 1 no. 6 in connection with sent. 2 WpHG and 1.97%
(224,993 voting rights) is to be attributed pursuant section 22 (1) sent. 1
no. 6 WpHG.
2nd voting rights anouncement
FIL Investment Management Limited, Hildenborough, Kent, UK, has notified us
pursuant to section 21 (1) WpHG on 21 May 2010, that on 17 May 2010 the
share of voting rights in STRATEC Biomedical Systems AG, Birkenfeld,
Germany, ISIN: DE0007289001 fell below the threshold of 3% and that the
percentage of voting rights on that day amounted to 2.04% (233,373 votings
rights).
All voting rights in STRATEC Biomedical Systems AG were attributed to FIL
Investment Management Limited pursuant to section 22 (1) sent. 1 no. 6 in
connection with sent. 2 WpHG.
3rd voting rights anouncement
Fidelity Funds SICAV, Luxembourg, Luxembourg, has notified us pursuant to
section 21 (1) WpHG on 21 May 2010, that on 17 May 2010 the share of voting
rights in STRATEC Biomedical Systems AG, Birkenfeld, Germany, ISIN:
DE0007289001 fell below the threshold of 3% and that the percentage of
voting rights on that day amounted to 1.84% (210,383 voting rights).
4th voting rights anouncement
FIL Investments International, Hildenborough, Kent, UK, has notified us
pursuant to section 21 (1) WpHG on 21 May 2010, that on 17 May 2010 the
share of voting rights in STRATEC Biomedical Systems AG, Birkenfeld,
Germany, ISIN: DE0007289001 fell below the threshold of 3% and that the
percentage of voting rights on that day amounted to 1.97% (224,993 voting
rights).
All voting rights in STRATEC Biomedical Systems AG were attributed to FIL
Investments International pursuant to section 22 (1) sent. 1 no. 6 WpHG.
5th voting rights anouncement
FIL Investment Management Limited, Hildenborough, Kent, UK, has notified us
pursuant to section 21 (1) WpHG on 21 May 2010, that on 17 May 2010 the
share of voting rights in STRATEC Biomedical Systems AG, Birkenfeld,
Germany, ISIN: DE0007289001 fell below the threshold of 3% and that the
percentage of voting rights on that day amounted to 1.97% (224,993 votings
rights).
All voting rights in STRATEC Biomedical Systems AG were attributed to FIL
Holdings Limited pursuant to section 22 (1) sent. 1 no. 6 in connection
with sent. 2 WpHG.
01.06.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: STRATEC Biomedical Systems AG
Gewerbestraße 37
75217 Birkenfeld
Deutschland
Internet: www.stratec-biomedical.de
End of News DGAP News-Service
---------------------------------------------------------------------------